Dubai: In a groundbreaking achievement for global cardiac care, Dr. Mohamed Magdi, a consultant and Head of the Cardiac Electrophysiology Department at Al Qassimi Hospital in Sharjah, led Europe’s first implantation of the “Aveir VR,” a single-chamber, wireless cardiac pacemaker, at Bern University Hospital in Switzerland.
The milestone solidifies the nation’s leadership in advanced medical technology. The UAE became the second country worldwide, after the United States, to adopt this state-of-the-art technology.
Dr. Magdi was invited to perform the pioneering procedure, demonstrating the UAE’s growing influence in healthcare and medical innovation. His expertise with the Aveir VR device reflects the UAE’s proactive approach in implementing cutting-edge solutions to improve patient care. Al Qassimi Hospital in Sharjah has been instrumental in this field, actively working to push the boundaries of cardiac technology.
Dr. Arif Al Nooryani, Director of Al Qassimi Hospital, stated that, “We are proud to see our specialists at the forefront of such medical advancements. Leading Europe’s first wireless pacemaker implantation is a testament to the UAE’s commitment to innovation and our dedication to training highly skilled professionals.” Dr. Al Nooryani credited the achievements to the support of Emirates Health Services, which continues to equip the healthcare sector with state-of-the-art technology, advancing the “We the UAE 2031” vision and UAE Centennial 2071 goals.
Additionally, Al Nooryani highlighted Al Qassimi Hospital’s partnerships with international medical institutions and the impact of its specialized training programs. These efforts have led to over 200 doctors from Europe and the Middle East, including countries like Switzerland, Germany, and France, receiving training in this revolutionary pacemaker technology.
Dr. Magdi remarked that, “It is an honor for Al Qassimi Hospital to play a leading role in cardiac innovation. Since our first device implantation over ten months ago, we’ve witnessed transformative outcomes, and this technology is a significant step forward in cardiac care.”